Product Overview
The Recombinant Factor C Endotoxin Detection Kit provides a modern alternative to traditional limulus amebocyte lysate (LAL)-based endotoxin testing, suitable for a broad range of applications including human and animal injectable drugs (such as chemical drugs, radiopharmaceuticals, antibiotics, and biological products) and medical devices (such as dialysate and implantable devices). The kit supports endotoxin testing across raw and auxiliary materials, intermediate products, and released final products, addressing quality control needs throughout the manufacturing pipeline. Built on recombinant Factor C technology, this kit offers a highly sensitive, highly specific, and stable method for endotoxin detection, without dependence on animal-derived components — addressing sustainability and supply chain reliability concerns associated with horseshoe crab-derived LAL reagents. The assay is capable of quantifying endotoxin concentrations across a range of 0.005–5 EU/mL, supporting sensitive detection suitable for both trace-level screening and higher-concentration quality control applications.
Components
| Reagent | 48T | 96T |
| Fluorescent substrate solution | 3 mL | 6 mL |
| Measuring buffer | 2.5 mL | 5 mL |
| rFC enzyme solution | 0.6 mL | 1.2 mL |
| LAL reagent water | 30 mL | 30 mL |
| Control standard endotoxin | 1 vial | 2 vials |
| 96-well non-pyrogenic detachable reaction plate | 1 Pc | 1 Pc |
Product Features
- Animal-free, sustainable endotoxin testing: Based on recombinant Factor C technology rather than animal-derived limulus amebocyte lysate, this kit eliminates reliance on horseshoe crab-derived reagents, supporting more sustainable and consistently available endotoxin testing supply.
- High sensitivity and broad quantification range: The assay quantifies endotoxin concentrations across a range of 0.005–5 EU/mL, providing the sensitivity needed to detect low-level endotoxin contamination as well as broader quantification for routine quality control testing.
- Broad applicability across drug and device testing: Suitable for testing raw materials, intermediates, and released products across injectable pharmaceuticals (chemical drugs, radiopharmaceuticals, antibiotics, biologics) and medical devices (dialysate, implantable devices), the kit supports endotoxin quality control across diverse product categories and manufacturing stages.
FAQ
Q1: How does recombinant Factor C technology differ from traditional LAL-based endotoxin testing?
Traditional LAL reagents are derived from the blood of horseshoe crabs and rely on the natural coagulation cascade triggered by endotoxin exposure. Recombinant Factor C technology instead uses a single recombinant protein — Factor C, the primary endotoxin-sensing component of the LAL cascade — produced without animal-derived materials. This provides a functionally analogous detection mechanism while removing dependence on wild-caught horseshoe crab populations and offering more consistent reagent lot-to-lot performance.
Q2: What is the detection range of this kit, and is it sensitive enough for trace-level endotoxin screening?
The kit quantifies endotoxin concentrations across a range of 0.005–5 EU/mL, providing high sensitivity suitable for detecting trace endotoxin contamination in raw materials and intermediates, as well as broader quantification for release testing of finished products, depending on the applicable specification limits for a given product type.
Q3: Can this kit be used for both pharmaceutical and medical device endotoxin testing?
Yes. This kit is designed for endotoxin detection across both injectable pharmaceutical products (including chemical drugs, radiopharmaceuticals, antibiotics, and biological products) and medical devices (such as dialysate and implantable devices), supporting endotoxin quality control across raw materials, intermediates, and released products in both product categories.